CNS Pharmaceuticals, Inc. (CNSP)
5.75
-0.19
(-3.20%)
USD |
NASDAQ |
Sep 09, 16:00
5.75
0.00 (0.00%)
After-Hours: 17:45
CNS Pharmaceuticals Total Assets (Quarterly) : 21.94M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 21.94M |
| March 31, 2026 | 4.653M |
| December 31, 2025 | 8.624M |
| September 30, 2025 | 11.87M |
| June 30, 2025 | 14.51M |
| March 31, 2025 | 13.75M |
| December 31, 2024 | 8.701M |
| September 30, 2024 | 7.409M |
| June 30, 2024 | 2.469M |
| March 31, 2024 | 1.661M |
| December 31, 2023 | 1.701M |
| September 30, 2023 | 2.328M |
| June 30, 2023 | 6.452M |
| March 31, 2023 | 7.415M |
| December 31, 2022 | 13.05M |
| September 30, 2022 | 9.638M |
| Date | Value |
|---|---|
| June 30, 2022 | 12.45M |
| March 31, 2022 | 15.87M |
| December 31, 2021 | 8.757M |
| September 30, 2021 | 11.51M |
| June 30, 2021 | 14.24M |
| March 31, 2021 | 13.14M |
| December 31, 2020 | 15.85M |
| September 30, 2020 | 2.985M |
| June 30, 2020 | 3.986M |
| March 31, 2020 | 6.211M |
| December 31, 2019 | 7.912M |
| September 30, 2019 | 1.398M |
| June 30, 2019 | 1.642M |
| March 31, 2019 | 0.5526M |
| December 31, 2018 | 0.6833M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.494B |
| Corcept Therapeutics, Inc. | 888.70M |
| Veru, Inc. | 37.03M |
| Johnson & Johnson | 201.06B |
| Eli Lilly & Co. | 142.28B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 3.738M |
| Shareholders Equity (Quarterly) | 18.20M |
| Current Ratio | 5.845 |
| Net Debt Paydown Yield | 0.60% |